InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aldeyra Therapeutics, Inc.

ALDX Clue Score54
United States Fiscal year ends December CIK 0001341235
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Machatha
11 Aug 2025
Chief Development Officer
Sell
22,073
$5.15
$113.71K
Perceptive Advisors LLC
3 Apr 2025
10% owner
Sell indirect
3,400,000
$1.42
$4.83M
Bruce Greenberg
12 Aug 2024
See Remarks
Sell
10,834
$4.74
$51.31K
Stephen Machatha
12 Aug 2024
Chief Development Officer
Sell
16,041
$4.74
$75.97K
Todd C Brady
12 Mar 2024
President and CEO
Sell
85,324
$3.05
$260.24K
Stephen Machatha
12 Mar 2024
Chief Development Officer
Sell
11,537
$3.16
$36.50K
Todd C Brady
11 Mar 2024
President and CEO
Sell
97,914
$3.27
$320.52K
Stephen Machatha
11 Mar 2024
Chief Development Officer
Sell
18,231
$3.41
$62.10K
Bruce Greenberg
11 Mar 2024
See Remarks
Sell
13,201
$3.41
$44.97K
Perceptive Advisors LLC
18 Oct 2023
10% owner
Sell indirect
306,499
$1.74
$533.31K
Perceptive Advisors LLC
16 Oct 2023
10% owner
Sell indirect
2,450,000
$1.60
$3.92M
Jesse I Treu
26 Mar 2019
Director
Sell indirect
445
$10.01
$4.45K
Jesse I Treu
26 Mar 2019
Director
Sell indirect
96,298
$10.01
$963.94K
Show all 76 transactions →

What was left out

Form 4 filings counted 151
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 2,657,507
Sales filed before the plan box existed 2
History held since 5 May 2014